Description of Patients With Type 1 Diabetes Treated With Teplizumab

NCT06892002 · clinicaltrials.gov ↗

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Teplizumab

Sponsor

Sanofi